
0.2241 Delayed Data As of Aug 17 | ![]() Today’s Change | 0.21 Today|||52-Week Range 1.32 | -63.60% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Corbus Pharmaceuticals Holdings Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +1,238.69% increase from the last price of 0.22.
The current consensus among 2 polled investment analysts is to Buy stock in Corbus Pharmaceuticals Holdings Inc. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.